AC-ARG-ARG-TRP-TRP-CYS-ARG-NH2 manufacturers
- Antileukinate
-
- $570.00 / 1mg
-
2024-10-24
- CAS:138559-60-1
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | AC-ARG-ARG-TRP-TRP-CYS-ARG-NH2 Basic information |
| Product Name: | AC-ARG-ARG-TRP-TRP-CYS-ARG-NH2 | | Synonyms: | IL-8 INHIBITOR;AC-ARG-ARG-TRP-TRP-CYS-ARG-NH2;AC-RRWWCR-NH2;IL-8 Inhibitor, Antileukinate;L-Argininamide, N2-acetyl-L-arginyl-L-arginyl-L-tryptophyl-L-tryptophyl-L-cysteinyl-;IL-8 Inhibitor - 1 mg;Interleukin-8 Inhibitor | | CAS: | 138559-60-1 | | MF: | C45H66N18O7S | | MW: | 1003.19 | | EINECS: | | | Product Categories: | | | Mol File: | 138559-60-1.mol |  |
| | AC-ARG-ARG-TRP-TRP-CYS-ARG-NH2 Chemical Properties |
| density | 1.52±0.1 g/cm3(Predicted) | | storage temp. | -15°C | | solubility | DMF: 1 mg/ml; DMSO: 5 mg/ml; PBS (pH 7.2): 2 mg/ml | | form | Solid | | pka | 9.16±0.10(Predicted) |
| | AC-ARG-ARG-TRP-TRP-CYS-ARG-NH2 Usage And Synthesis |
| Uses | Antileukinate is a CXC-chemokine receptor antagonist, inhibiting neutrophil influx into the lung following a variety of pulmonary insults. Antiinflammatory agent. | | in vivo | Antileukinate (52.63 mg/kg; s.c.) protectes mice against acute pancreatitis and associated lung injury[1].
Antileukinate (5mg/kg; s.c.) inhibits the interaction between murine eotaxin and murine eosinophil[2].
| Animal Model: | Swiss mice (20-25g)[1] | | Dosage: | 52.63 mg/kg | | Administration: | Subcutaneous injection | | Result: | Reduced pancreatic edema induced by Caerulein (50 μg/kg). |
|
| | AC-ARG-ARG-TRP-TRP-CYS-ARG-NH2 Preparation Products And Raw materials |
|